# To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

> **NCT00244296** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 276 (—)

## Conditions studied

- Urinary Incontinence, Stress

## Interventions

- **DRUG:** Duloxetine hydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00244296
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 276 (—)
- **Last updated:** 2007-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244296, "To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00244296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*